Opinion: The coronavirus outbreak exposes the U.S.’s pharma supply chain vulnerability
400,000 new jobs have been created in the U.S. domestic manufacturing sector. We must focus this momentum and begin bringing pharmaceutical manufacturing jobs back to the U.S.
In the 21st century, Americans have found it far too easy to be complacent about public health emergencies like the ongoing coronavirus outbreak of the newly named Covid-19 that began in China and has since spread to other countries, including the U.S.
To be fair, it has been more than 50 years since the last federal quarantine was issued, to control a . A half-century gap is bound to instill a false sense of security, even when taking more recent threats into consideration.
